{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"3.80","value":"14.00"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"10"}],"units":"Participants"}],"description":"Average number of day per patient for absolute neutrophil count to recover(\\> 500/mm3 for 3 consecutive days).","dispersionType":"Standard Deviation","groups":[{"description":"All patients that received Basiliximab 20 mg monoclonal therapy","id":"OG000","title":"Basiliximab 20 mg"}],"paramType":"MEAN","populationDescription":"ITT: All patient that received study drug","timeFrame":"From Day -1 (day before stem cell infusion) to Day+20 (20 days after stem cell infusion)","title":"Number of Days for Absolute Neutrophil Count to Recover","type":"SECONDARY","unitOfMeasure":"days per patient"}